Neuroleptic malignant syndrome

Neuroleptic malignant syndrome (NMS) is an idiosyncratic condition associated with administration of antipsychotic and other central dopaminergic blockers, and characterized by hyperthermia, muscular rigidity, autonomic dysfunction and altered consciousness.

Also known as: NMS

1 clinical trial for this condition and its sub-types.